Fenofibrate: A new treatment for hyperuricaemia and gout? [2]

Annals of the Rheumatic Diseases

Volumn 60, Issue 10, 2001, Pages 984-986

  Hepburn, A L ^a   Kaye, S A ^a   Feher, M D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FENOFIBRATE;

ADULT; AGED; CASE REPORT; DRUG EFFICACY; DRUG TOLERANCE; GOUT; HUMAN; HYPERCALCIURIA; LETTER; MALE; PRIORITY JOURNAL; TREATMENT INDICATION; URIC ACID BLOOD LEVEL;

ADULT; AGED; ALLOPURINOL; DRUG THERAPY, COMBINATION; GOUT; GOUT SUPPRESSANTS; HUMANS; MALE; MIDDLE AGED; PROCETOFEN; TREATMENT OUTCOME;

EID: 0034828474     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.10.984     Document Type: Letter

References (10)

1. Uricosuric effect of fenofibrate in healthy volunteers
2. Hypolipidaemic and hypouricaemic action of fenofibrate in various types of hyperlipoproteinaemia
3. Hypertriglyceridaemia and hyperuricaemia: Effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind placebo-controlled trial
4. Atherogenic lipoprotein phenotype in type 2 diabetes: Reversal with micronised fenofibrate
5. Hyperuricaemia and hypertriglyceridaemia: Metabolic basis for the association
6. Hyperlipidaemia in hyperuricaemia and gout
7. Blood lipid and uric acid interrelationships
8. Hypertriglyceridaemia in gout
9. Serum uric acid and cardiovascular mortality. The NHANES 1/epidemiologic follow-up study 1971-92
10. Serum uric acid and the risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study